BMMX Stock Overview
Biomimix, Inc. operates in the life science tools and services market covering genomics, proteomics, cell biology, analytical chemistry, bioprocess development, and bioinformatics in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Biomimix, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0002 |
| 52 Week High | US$0.0002 |
| 52 Week Low | US$0.0002 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -94.29% |
| 5 Year Change | -93.75% |
| Change since IPO | -99.97% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| BMMX | US Life Sciences | US Market | |
|---|---|---|---|
| 7D | 0% | -4.9% | -3.7% |
| 1Y | n/a | -4.3% | 20.5% |
Return vs Industry: Insufficient data to determine how BMMX performed against the US Life Sciences industry.
Return vs Market: Insufficient data to determine how BMMX performed against the US Market.
Price Volatility
| BMMX volatility | |
|---|---|
| BMMX Average Weekly Movement | n/a |
| Life Sciences Industry Average Movement | 7.0% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: BMMX has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine BMMX's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1986 | n/a | Jeff Conroy | www.biomimix.net |
Biomimix, Inc. operates in the life science tools and services market covering genomics, proteomics, cell biology, analytical chemistry, bioprocess development, and bioinformatics in the United States. It develops and commercializes products based on processes and systems found in nature, known as biomimicry. The company’s product portfolio includes Bonegrafix products, which are bioactive substances to produce graft attributes for bone replacement and filling defects or holes in bone, or stabilizing bone during the healing process; and ocean water based skin care products to supplement skin health.
Biomimix, Inc. Fundamentals Summary
| BMMX fundamental statistics | |
|---|---|
| Market cap | US$8.02k |
| Earnings (TTM) | -US$182.45k |
| Revenue (TTM) | US$34.76k |
0.0x
P/S Ratio0.0x
P/E RatioIs BMMX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BMMX income statement (TTM) | |
|---|---|
| Revenue | US$34.76k |
| Cost of Revenue | US$8.17k |
| Gross Profit | US$26.59k |
| Other Expenses | US$209.04k |
| Earnings | -US$182.45k |
Last Reported Earnings
Dec 31, 2009
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did BMMX perform over the long term?
See historical performance and comparison